LEPR and breast carcinoma: First, we tested the biological activity of the peptide LDFI on anchorage-dependent cell proliferation using as experimental models ObR-positive and leptin-sensitive MCF-7 (ERα-positive) and SKBR3 (ERα-negative) breast cancer cells.